Gilgamesh Pharma, Inc.
Records under this name other than the patents Gilgamesh Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Gilgamesh Pharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 17/714,879 | Arylcyclohexylamine Derivatives and Their Use in the Treatment of Psychiatric Disorders Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 17/973,119 | Novel Ergolines and Methods of Treating Mood Disorders Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/024,545 | Azetidinyl Tryptamines and Methods of Treating Psychiatric Disorders Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/281,127 | Phenalkylamines and Methods of Making and Using the Same Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/287,980 | Novel Ergolines and Methods of Treating Mood Disorders Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/289,476 | Novel Tryptamines and Methods of Treating Mood Disorders Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/294,360 | Methods of Treating Neuropsychiatric Disorders Abandoned Abandoned Oct 28, 2026 | Abandoned | Abandoned Oct 28, 2026 | |
| 18/572,861 | Arylcyclohexylamine Derivatives and Their Use in the Treatment of Psychiatric Disorders Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/686,059 | Combinations of Peripheral 5-HT2A Receptor Antagonists and Central 5-HT2A Receptor Agonists Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/837,417 | (AMPAR-PAM)-Nmda Receptor Antagonist Combination Therapy for Treatment of Mental Conditions and Disorders Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |